Indefinite Delivery Contract SPE2DB25D9336

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued up to $499,999,999, covers a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide under the SPE2DB program.

The contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive portfolio of medications, including branded and generic prescription drugs, over-the-counter products, biologics, and medical consumables. Key product categories include flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. This IDC complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) healthcare sites, solidifying the company's position as a critical supplier in the federal pharmaceutical supply chain.